Principal Financial Group Inc Veracyte, Inc. Transaction History

Principal Financial Group Inc

$160 Billion
Q2 2024

A detailed history of Principal Financial Group Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 45,198 shares of VCYT stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,198

Previous 47,704 5.25%

Holding current value

$1.53 Million

Previous $1.06 Million 7.38%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$18.86 - $23.55 $47,263 - $59,016	-2,506 Reduced 5.25%	45,198 $979,000
Q1 2024 Apr 29, 2024	SELL	$21.0 - $29.1 $74,067 - $102,635	-3,527 Reduced 6.88%	47,704 $1.06 Million
Q4 2023 Feb 07, 2024	BUY	$19.72 - $28.68 $129,461 - $188,284	6,565 Added 14.7%	51,231 $1.41 Million
Q3 2023 Nov 02, 2023	BUY	$22.33 - $29.92 $283,010 - $379,206	12,674 Added 39.62%	44,666 $997,000
Q2 2023 Aug 07, 2023	BUY	$20.96 - $26.99 $274,177 - $353,056	13,081 Added 69.17%	31,992 $814,000
Q1 2023 May 09, 2023	BUY	$20.58 - $27.89 $64,127 - $86,905	3,116 Added 19.73%	18,911 $421,000
Q4 2022 Feb 09, 2023	BUY	$15.31 - $29.94 $2,388 - $4,670	156 Added 1.0%	15,795 $374,000
Q3 2022 Nov 09, 2022	BUY	$16.58 - $27.9 $64,711 - $108,893	3,903 Added 33.26%	15,639 $260,000
Q2 2022 Aug 10, 2022	BUY	$15.45 - $29.52 $57,226 - $109,342	3,704 Added 46.12%	11,736 $234,000
Q1 2022 May 09, 2022	SELL	$21.94 - $42.51 $138,902 - $269,130	-6,331 Reduced 44.08%	8,032 $221,000
Q4 2021 Feb 09, 2022	SELL	$36.09 - $53.79 $180,558 - $269,111	-5,003 Reduced 25.83%	14,363 $592,000
Q3 2021 Nov 09, 2021	SELL	$35.62 - $52.97 $138,490 - $205,947	-3,888 Reduced 16.72%	19,366 $900,000
Q2 2021 Aug 10, 2021	SELL	$32.94 - $56.62 $114,828 - $197,377	-3,486 Reduced 13.04%	23,254 $929,000
Q1 2021 May 10, 2021	BUY	$44.47 - $81.38 $24,636 - $45,084	554 Added 2.12%	26,740 $1.44 Million
Q4 2020 Feb 08, 2021	BUY	$32.49 - $61.88 $234,967 - $447,516	7,232 Added 38.16%	26,186 $1.28 Million
Q3 2020 Nov 06, 2020	BUY	$26.73 - $35.67 $7,163 - $9,559	268 Added 1.43%	18,954 $615,000
Q2 2020 Aug 05, 2020	SELL	$19.49 - $28.11 $390,033 - $562,537	-20,012 Reduced 51.71%	18,686 $484,000
Q1 2020 May 12, 2020	BUY	$16.13 - $30.17 $7,258 - $13,576	450 Added 1.18%	38,698 $941,000
Q4 2019 Feb 05, 2020	BUY	$20.78 - $29.99 $345,841 - $499,123	16,643 Added 77.03%	38,248 $1.07 Million
Q3 2019 Nov 13, 2019	BUY	$23.87 - $30.93 $21,435 - $27,775	898 Added 4.34%	21,605 $519,000
Q2 2019 Aug 12, 2019	BUY	$22.1 - $28.56 $457,624 - $591,391	20,707 New	20,707 $590,000

Others Institutions Holding VCYT

# of Institutions

254

Shares Held

82.1M

Call Options Held

42.3K

Put Options Held

18.2K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.42B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Veracyte, Inc. Transaction History